GC Corp. (KOSE: A005250)
Health Care · Biotechnology · KR
₩9,750.00
+0.72% today · -37.1% 1Y
GC Corp. (KOSE: A005250) operates in the Biotechnology industry within the Health Care sector. The company is valued at $329.56M.
Over the last twelve months the share price has lost 37.1%, trading between 8.63K and 18.01K.
Tweenvest scores GC Corp. across four factors: quality 55/100, value 58/100, dividend 69/100. Its strongest factor is dividend.
A005250 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $329.56M
- Revenue (TTM)
- $1.61B
- P/E
- —
- EPS
- -2,698.71
- Dividend yield
- 3.08%
- Beta (5Y)
- 0.56
- 52-week high
- ₩18,010.00
- 52-week low
- ₩8,630.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ROKIT Healthcare Inc.KOSDAQ: A376900 | $346.80M | ₩26,850.00 | -3.24% |
| Agenus Inc.NasdaqCM: AGEN | $334.50M | $7.43 | -3.13% |
| Indaptus Therapeutics, Inc.NasdaqCM: INDP | $334.44M | $2.44 | -2.79% |
| Artiva Biotherapeutics, Inc.NasdaqGM: ARTV | $330.99M | $6.77 | -2.45% |
| 3-D Matrix, Ltd.TSE: 7777 | $328.96M | ¥407.00 | -3.10% |
| TWi Biotechnology, Inc.TPEX: 6610 | $322.75M | NT$50.20 | +11.43% |
| Ocugen, Inc.NasdaqCM: OCGN | $321.21M | $0.95 | -0.87% |
| Circio Holding ASAOB: CRNA | $319.79M | Nkr11.04 | -0.90% |
Figures last refreshed Oct 11, 2026.